Antimicrobial resistance in community-acquired respiratory tract pathogens.
Antimicrobial resistance among common respiratory pathogens has become a significant problem. However, there remain multiple treatment options, including the newer macrolides, third-generation cephalosporins, beta-lactam/beta-lactamase inhibitor antibiotics, and the newer fluoroquinolones.
Lark
R L
RL
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA.
Chenoweth
C
C
D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D005060:Europe / Q000453:epidemiology; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D001936:Moraxella catarrhalis / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D014481:United States / Q000453:epidemiology